Contact Us
9 December 2010
Posted In

RDC5 Reduces the Levels of Toxic Protein Aggregates

In pre-clinical models, Chronos Therapeutics' patented compound RDC5 and CHR1 (originally identified via the Chronoscreen™)show significant effects on pre-clinical model systems of neurodegeneration. Both compounds appear to not only reduce the formation of visible aggregates but also promote the degradation of neuro-toxic proteins.

About Sibelius Natural Products
Sibelius is a developer and marketer of high-value, clinically validated natural ingredients for use in dietary supplements, foods and beverages. The company is focused on building modern scientific evidence behind well-known botanicals, helping consumers to make informed decisions about the supplements they choose to purchase. Sibelius’ ingredient portfolio supports unique claims associated with cognition, sleep, anxiety, inflammation, cardiovascular health and men’s health. For more information, please fill in the form below:
Search
Categories
Subscribe to Our Newsletter
Keep up to date with the latest insights
news, events, developments and
product launches

How can we help you?

Please fill in the form below and a member of the team will get back to you. To read our privacy policy, click here.
crossmenu